Inhibitory Potency of Selected Therapeutic Bioactive Molecules of Standardized Terminalia arjuna (Roxb.) Extract on CYP3A4 and CYP2D6: Exploring Possible Herb-Drug Interactions.
暂无分享,去创建一个
[1] A. Agrawal,et al. Pharmacogenetic Comprised Prospect on Cytochrome P450 Facilitated Drug Interactions , 2013 .
[2] O. G. Nilsen,et al. In vitro Inhibition of CYP3A4 by the Multiherbal Commercial Product Sambucus Force and its Main Constituents Echinacea purpurea and Sambucus nigra , 2012, Phytotherapy research : PTR.
[3] P. Mukherjee,et al. Botanicals as medicinal food and their effects on drug metabolizing enzymes. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[4] P. Mukherjee,et al. Exploring the Possible Metabolism Mediated Interaction of Glycyrrhiza glabra Extract with CYP3A4 and CYP2D6 , 2011, Phytotherapy research : PTR.
[5] P. Mukherjee,et al. Cytochrome P450 inhibitory potential of Triphala--a Rasayana from Ayurveda. , 2011, Journal of ethnopharmacology.
[6] O. Pelkonen,et al. Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail , 2010, Xenobiotica; the fate of foreign compounds in biological systems.
[7] A. Kortenkamp,et al. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4). , 2010, Planta medica.
[8] Hua Yang,et al. Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes , 2009, Phytotherapy research : PTR.
[9] D. Carrier,et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. , 2008, Molecular nutrition & food research.
[10] Stephen Fowler,et al. In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug–Drug Interactions , 2008, The AAPS Journal.
[11] A. Kortenkamp,et al. Herbal extracts used for upper respiratory tract infections: are there clinically relevant interactions with the cytochrome P450 enzyme system? , 2008, Planta medica.
[12] Shufeng Zhou,et al. Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring , 2007, Therapeutic drug monitoring.
[13] Richard A. Friesner,et al. Flexible ligand docking with Glide. , 2007, Current protocols in bioinformatics.
[14] Jane Qiu,et al. China plans to modernize traditional medicine , 2007, Nature.
[15] H. Iwata,et al. Mechanism-based inhibition of CYP3A4 and CYP2D6 by Indonesian medicinal plants. , 2006, Journal of ethnopharmacology.
[16] S. Kadota,et al. Cytochrome P450 2D6 (CYP2D6) inhibitory constituents of Catharanthus roseus. , 2005, Biological & pharmaceutical bulletin.
[17] P. Frohberg,et al. A microtiterplate-based screening assay to assess diverse effects on cytochrome P450 enzyme activities in primary rat hepatocytes by various compounds. , 2005, Assay and drug development technologies.
[18] H. Cai,et al. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[19] A. D. Rodrigues,et al. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[20] Min Huang,et al. Interactions of Herbs with Cytochrome P450 , 2003, Drug metabolism reviews.
[21] S. Singhal,et al. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. , 2001, The Journal of the Association of Physicians of India.
[22] S. D. Turner,et al. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[23] M. Harkey,et al. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity. , 1999, Life sciences.
[24] S. Dwivedi,et al. Beneficial effects of Terminalia arjuna in coronary artery disease. , 1997, Indian heart journal.
[25] A. Bharani,et al. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. , 1995, International journal of cardiology.
[26] S. Dwivedi,et al. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. , 1994, The Journal of the Association of Physicians of India.
[27] S. Verma,et al. Current and future status of herbal medicines , 2008 .
[28] Y. Kohno,et al. Application of microtiter plate assay to evaluate inhibitory effects of various compounds on nine cytochrome P450 isoforms and to estimate their inhibition patterns. , 2002, Drug metabolism and pharmacokinetics.
[29] HighWire Press,et al. Drug metabolism and disposition : the biological fate of chemicals. , 1973 .